AGP Executive Report
Last update: 6 hours agoAI-Driven Biotech: Nvidia-backed Iambic Therapeutics raised $150 million in its IPO, with shares climbing 16% on debut. The company uses AI to help discover cancer drugs. Separately, the first patient has been dosed in a trial testing systemic DNase alongside CAR T-cell therapy for large B-cell lymphoma; initial results are expected in 2027. Industrial Robotics: Hong Kong opened a hub to train humanoid robots in simulated real-world tasks and speed their use in manufacturing, logistics and public services. AI Infrastructure: Siemens is backing Skeleton Technologies’ supercapacitors to smooth rapid power swings at AI data centers. Smartphone Market: Global shipments fell 22% in the third quarter, according to IDC, as soaring memory costs—driven by demand from AI data centers—squeezed device makers. Digital Health: Epic plans a tool for clinicians and patients to compare prescription prices across pharmacies before sending a prescription, with launch set for summer 2027.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[American Pharmacists Month: Celebrating the Pharmacist’s Community Role]]>](https://cdn.sanity.io/images/0vv8moc6/drugtopics/bd2801433b90dd5e8c0234d8da904c4660eabd68-800x593.jpg)
